ATB Therapeutics

Pioneering biopharmaceutical company building a new line of attack against cancer.

HQ location

Belgium

Website

Launch date

Jul 2017

Employees

Enterprise value

$238—356m

Date	Investors	Amount	Round
Nov 2024*	EQT Life Sciences Sambrinvest SFPIM V-Bio Ventures Vives Partners MRL Ventures Wallonie Entreprendre	€54.0m	Series A
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads